ESPE Abstracts

ESPE Abstracts

Scientific Programme, ePosters & Abstracts

Published by BioScientifica
Previous issue | Volume 92 | ESPE2019 | Next issue

58th Annual ESPE (ESPE 2019)

Free Communications

Bone, Growth Plate and Mineral Metabolism Session 1

Previous section
Diabetes and Insulin Session 1
Table of contents
Next section
Multi-system Endocrine Disorders

hrp0092fc2.1 | Bone, Growth Plate and Mineral Metabolism Session 1

Continued Improvement in Clinical Outcomes with Burosumab, a Fully Human Anti-FGF23 Monoclonal Antibody: Results from a 3-Year, Phase 2, Clinical Trial in Children with X-Linked Hypophosphatemia (XLH)

hrp0092fc2.2 | Bone, Growth Plate and Mineral Metabolism Session 1

Benefits of Long-Term Burosumab Persist in 11 Girls with X-Linked Hypophosphatemia (XLH) Who Transitioned into Adolescence During the Phase 2 CL201 Trial

hrp0092fc2.3 | Bone, Growth Plate and Mineral Metabolism Session 1

Higher Dose of Burosumab is Needed for Treatment of Children with Severe Forms of X-Linked Hypophosphatemia

hrp0092fc2.4 | Bone, Growth Plate and Mineral Metabolism Session 1

New Imaging Approaches to the Quantification of Musculoskeletal Alterations in X-Linked Hypophosphatemic Rickets (XLH)

hrp0092fc2.5 | Bone, Growth Plate and Mineral Metabolism Session 1

Age and Gender-Specific Reference Data for High-Resolution Magnetic Resonance Based Musculoskeletal Parameters in Healthy Children and Young People

hrp0092fc2.6 | Bone, Growth Plate and Mineral Metabolism Session 1

Validation of a New Version of BoneXpert Bone Age in Children with Congenital Adrenal Hyperplasia (CAH), Precocious Puberty (PP), Growth Hormone Deficiency (GHD), Turner Syndrome (TS), and other Short Stature Diagnoses

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2026 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more